Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Chiba University
Age
13–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Diagnosis of PTSD based on DSM-IV-TR criteria.
2. Score of 25 or higher on the IES-R.
3. currently is an outpatient at Chiba University Hospital Department of Psychiatry or Child Psychiatry .
4. currently receiving no medications for PTSD treatment with any of the following medications : Antidepressants (SSRI ; Fluvoxamine, Paroxetine, Sertraline, Escitalopram, SNRI ; Milnacipran, Duloxetine, NaSSa; Mirtazapine), Mood stabilizers (Lithium, Sodium Valproate, Carbamazepine, Lamotrigine), Atypical antipsychotics (Risperidone, Olanzapine, Quetiapine, Perospirone, Aripiprazole, Blonanserin, Paliperidone) .
5. Ages 13 - 18, male or female
6. be stable on any medications for PTSD treatment they may be taking for the previous 4 weeks prior to enrollment in this study.
7. Provision of written informed consent by patients and parents or guardian.
8. must be able to swallow powdered medicine.
7. receiving treatment with the following N-methyl-D-aspartate (NMDA) receptor antagonists: Ketamine hydrochloride, Amantadine hydrochloride, Memantine hydrochloride, dextromethorphan, Methadone) within 4 weeks prior to enrollment in this study.
8. pregnant or nursing, or intending to become pregnant or to start breastfeeding during the study.
9. participating in another clinical trial within 3 months prior to enrollment into this study. (except for observation study without intervention).
10. planning change of treatment because of unstable neurological manifestations or somatic symptoms.
11. History of suicidal ideation within the past year.
12. Other clinically significant reasons for exclusion by investigators.
You may not be if
1. History of allergic reaction or hypersensitivity to Ifenprodil Tartrate.
2. Patients who have not stopped bleeding after intracranial hemorrhage.
3. Patients who have not been informed of having the disease at the time of informed consent.
4. Diagnosis of any of the following diseases based on the DSM-IV-TR criteria. Mental Retardation, Pervasive Developmental Disorders, Attention-Deficit / Hyperactivity Disorder, Schizophrenia and Other Psychotic Disorders, Delirium, Dementia, and Amnestic and Other Cognitive Disorders, Substance-Related Disorders (except Caffeine-Related Disorders, Nicotine-Related Disorders) .
5. Somatic disorder which requires severe body management or severe meal management.
Clareo Health | Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial
